Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB

Blood

Volumn 98, Issue 3, 2001, Pages 743-753

  Ayroldi, Emira ^a   Migliorati, Graziella ^a   Bruscoli, Stefano ^a   Marchetti, Cristina ^a   Zollo, Ornella ^a   Cannarile, Lorenza ^a   D'Adamio, Francesca ^a   Riccardi, Carlo ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Dept of Clinical and Experimental Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; LEUCINE ZIPPER PROTEIN; PROTEIN SUBUNIT; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE ISOLATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; STEROID METABOLISM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE;

EID: 0035437169     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.3.743     Document Type: Article

References (66)

1. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev. 1982;65:133-155.
2. Barnes PJ, Adckock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993;14:436-441.
3. Hoffman GS. Immunosuppressive therapy for autoimmune diseases. Ann Allergy. 1993;70:263-274.
4. Wlemik PH. Leukemia and myeloma. In: Pinedo HM, Longo DL, Chabner BA, eds. Cancer Chemotherapy and Biological Response Modifiers. Amsterdam, The Netherlands: Elsevier Science; 1996;347-375.
5. Kwak LW, Longo DL Lymphomas. In: Pinedo HM, Longo DL, Chabner BA, eds. Cancer Chemotherapy and Biological Response Modifiers. Amsterdam, The Netherlands: Elsevier Science; 1996;376-440.
6. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJ. Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol. 1989;19:2175-2177.
7. MacDonald HR, Lees RK. Programmed death of autoreactive thymocytes. Nature. 1990;343:642-644.
8. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-399.
9. Boise LH, Thompson CG. Hierarchical control of lymphocyte survival. Science. 1996;274:67-68.
10. Backstrom BT, Muller U, Hausmann B, Palmer E. Positive selection through a motif in the αβ T cell receptor. Science. 1998;281:835-838.
11. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 1990;63:1249-1254.
12. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today. 1993;14:333-339.
13. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989;243:355-361.
14. Alderson ML, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med. 1995;181:71-77.
15. Dhein J, Walczak H, Baumier C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 1995;373:438-441.
16. Ju ST, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995;373:444-448.
17. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol. 1995;154:3806-3813.
18. Green DR, Ware CF. Fas-ligand: privilege and peril. Proc Natl Acad Sci U S A. 1997;94:5986-5990.
19. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 1995;7:333-342.
20. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med. 1997;185:1897-1907.
21. Kuo CT, Veselits ML, Leiden JM. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science. 1997;277:1886-1990.
22. Maggirwar SB, Harhaj EW, Sun SC. Regulation of the interleukin-2 CD28 responsive element by NF-ATp and various NF-kappaB/Rel transcription factors. Mol Cell Biol. 1997;17:2605-2614.
23. Gerondakis S, Grumont R, Ropurke R, Grossman M. The regulation and roles of Rel/NF-kappaB transcription factors during lymphocyte activation. Curr Opin Immunol. 1998;10:353-359.
24. Lin B, Williams-Skipp C, Tao Y, et al. NF-κB functions as both proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 1999;6:570-582.
25. Nieto MA, Gonzales A, Lopez-Rivas A, Diaz Espada F, Gambon F. IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol. 1990;145:1364-1368.
26. Linsley PS, Brady W, Grossmare LS, Aruffo A, Damle NK, Ledbetter JA. Binding of B-cell activation antigen B7 to CD28 costimulates T-cell proliferation and interleukin-2 mRNA accumulation. J Exp Med. 1991;173:721-732.
27. Seder RA, Paul WE, Davis MM, Fazekas de St Groth B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med. 1992;176:1091-1099.
28. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1972;284:555-558.
29. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 1984;132:38-43.
30. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med. 1994;179:1835-1846.
31. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N Engl J Med. 1995;332:1351-1362.
32. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD. A targeted glucocorticoid receptor antisense transgene increases thymocyte development. Immunity. 1995;3:647-656.
33. Yang Y, Mercep M, Ware CF, Ashwell JD. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med. 1995;181:1673-1682.
34. Ramdas J, Harmon JM. Glucocorticoid-induced apoptosis and regulation of NF-Bκ activity in human leukemic T cells. Endocrinology. 1998;139:3813-3821.
35. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994;91:752-756.
36. Auphan N, DiDonato JA, Rosette C, Hejmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition by NF-κB activity through induction of IκB synthesis. Science. 1995;270:286-290.
37. Caldenhoven E, Liden J, Wissink S, et al. Negative cross-talk between Re-A and the glucocorticold receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol. 1995;9:401-412.
38. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283-286.
39. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of the mechanisms involved in the transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol. 1995;15:943-953.
40. De Bosscher K, Schimtz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A. 1997;94:13504-13509.
41. Riccardi C, Cifone G, Migliorati G. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ. 1999;12:1155-1163.
42. D'Adamio F, Zollo O, Moraca R, et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity. 1997;7:803-812.
43. Shimonkevitz R, Kappler J, Marrack P, Grey H. Antigen recognition by H-2-restricted T cells, I: cell-free antigen processing. J Exp Med. 1983;158:303-309.
44. Nocentini G, Giunchi L, Ronchetti S, et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci U S A. 1997;94:6216-6221.
45. Chang CC, Zhang J, Lombardi L, Neri A, Dalla-Favera R. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. Oncogene. 1994;9:923-933.
46. Powell JD, Ragheb JA, Kitagawa-Sakakida S, Schwartz RH. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev. 1998;165:287-300.
47. Migliorati G, Nicoletti I, Pagliacci MC, D'Adamio L, Riccardi C. Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood. 1993;81:1352-1358.
48. Ayroldi E, Migliorati G, Cannarile L, Moraca R, Delfino DV, Riccardi C. CD2 rescues T cell from T-cell receptor/CD3 apoptosis: a role for the Fas/FasL system. Blood. 1997;89:3717-3726.
49. Bours V, Franzoso G, Azarenko V, et al. The oncoprotein Bcl-3 directly transactivates through κ B motifs via association with DNA-binding p50B homodimers. Cell. 1993;72:729-739.
50. Franzoso G, Bours V, Azarenko V, et al. The oncoprotein Bcl-3 can facilitate NF-κ B-mediated transactivation by removing inhibiting p50 homodimers from select κ B sites. EMBO J. 1993;12:3893-3901.
51. Sanders B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and paraformaldehyde-saponin procedure. Immunol Rev. 1991;119:65-93.
52. Chen X, Zachar V, Zdravkovic M, Guo M, Ebbesen P, Liu X. Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator. J Gen Virol. 1997;78:3277-3285.
53. Kasibhatla S, Brunner T, Genstier L, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappaB and AP-1. Mol Cell. 1998;1:543-551.
54. Schreiber SL. Immunophyllin-sensitive protein phosphatase action in cell signalling pathways. Cell. 1992;70:365-368.
55. Migliorati G, Nicoletti I, D'Adamio F, Spreca A, Pagliacci C, Riccardi C. Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes. Immunology. 1994;81:21-26.
56. Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol. 1990;145:4037-4045.
57. Iwata M, Hanaoka S, Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol. 1991;21:643-648.
58. Cifone MG, Migliorati G, Parroni R, et al. Dexamethasone-induced thymocyte-apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase and caspases. Blood. 1999;93:2282-2296.
59. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 1998;8:615-623.
60. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 1999;11:281-288.
61. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 1995;376:167-170.
62. Grimm S, Bauer MKA, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol. 1996;134:13-23.
63. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-κ antiapoptosis: induction of TRAF1 and TRAF2 and c-P1 and c-P2 to suppress caspase-8 activation. Science. 1998;281:1680-1683.
64. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju S-T. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T-cell hybridoma. J Immunol. 1998;161:3469-3473.
65. Mittelstadt PR, Ashwell JD. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol. 1998;18:3744-3751.
66. Yang Y, Minucci S, Ozato K, Heyman RA, Ashwell JD. Efficient inhibition of activation-induced Fas ligand up-regulation and T-cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem. 1995;270:18672-18677.